Defining the profile: Characterizing cytokines in tendon injury to improve clinical therapy

Ilene M. Ellis , Lauren V. Schnabel , Alix K. Berglund
{"title":"Defining the profile: Characterizing cytokines in tendon injury to improve clinical therapy","authors":"Ilene M. Ellis ,&nbsp;Lauren V. Schnabel ,&nbsp;Alix K. Berglund","doi":"10.1016/j.regen.2022.100059","DOIUrl":null,"url":null,"abstract":"<div><p>Cytokine manipulation has been widely used to bolster innate healing mechanisms in an array of modern therapeutics. While other anatomical locations have a more definitive analysis of cytokine data, the tendon presents unique challenges to detection that make a complete portrayal of cytokine involvement during injury unattainable thus far. Without this knowledge, the advancement of tendon healing modalities is limited. In this review, we discuss what is known of the cytokine profile within the injured tendinous environment and the unique obstacles facing cytokine detection in the tendon while proposing possible solutions to these challenges. IL-1β, TNF-α, and IL-6 in particular have been identified as key cytokines for initiating tendon healing, but their function and temporal expression are still not well understood. Methods used for cytokine evaluation in the tendon including cell culture, tissue biopsy, and microdialysis have their strengths and limitations, but new methods and approaches are needed to further this research. We conclude that future study design for cytokine detection in the injured tendon should meet set criteria to achieve definitive characterization of cytokine expression to guide future therapeutics.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"16 ","pages":"Article 100059"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932644/pdf/nihms-1787468.pdf","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunology and regenerative medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468498822000014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

Abstract

Cytokine manipulation has been widely used to bolster innate healing mechanisms in an array of modern therapeutics. While other anatomical locations have a more definitive analysis of cytokine data, the tendon presents unique challenges to detection that make a complete portrayal of cytokine involvement during injury unattainable thus far. Without this knowledge, the advancement of tendon healing modalities is limited. In this review, we discuss what is known of the cytokine profile within the injured tendinous environment and the unique obstacles facing cytokine detection in the tendon while proposing possible solutions to these challenges. IL-1β, TNF-α, and IL-6 in particular have been identified as key cytokines for initiating tendon healing, but their function and temporal expression are still not well understood. Methods used for cytokine evaluation in the tendon including cell culture, tissue biopsy, and microdialysis have their strengths and limitations, but new methods and approaches are needed to further this research. We conclude that future study design for cytokine detection in the injured tendon should meet set criteria to achieve definitive characterization of cytokine expression to guide future therapeutics.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
定义概况:表征肌腱损伤中的细胞因子以改善临床治疗
细胞因子操纵已被广泛用于支持先天愈合机制在一系列现代治疗。虽然其他解剖位置对细胞因子数据有更明确的分析,但肌腱的检测面临着独特的挑战,这使得损伤期间细胞因子参与的完整描述迄今为止无法实现。没有这些知识,肌腱愈合方式的进步是有限的。在这篇综述中,我们讨论了损伤肌腱环境中已知的细胞因子特征,以及在肌腱中检测细胞因子所面临的独特障碍,同时提出了应对这些挑战的可能解决方案。特别是IL-1β、TNF-α和IL-6已被确定为启动肌腱愈合的关键细胞因子,但它们的功能和时间表达仍不清楚。用于评估肌腱细胞因子的方法包括细胞培养、组织活检和微透析,各有其优势和局限性,但需要新的方法和途径来进一步研究。我们的结论是,损伤肌腱中细胞因子检测的未来研究设计应符合设定的标准,以实现细胞因子表达的明确表征,以指导未来的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A decade of progress: Achievements and future challenges for regenerative medicine research in the United Kingdom The past, present, and future promise of pluripotent stem cells The past, present, and future promise of pluripotent stem cells Expanding the horizons of cell-based immunotherapies: CAR-neutrophils Xenotransplantation – has its time finally arrived?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1